Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.
Lévi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, Chollet P, Garufi C, Itzhaki M, Dogliotti L, et al. Lévi FA, et al. Among authors: itzhaki m. J Natl Cancer Inst. 1994 Nov 2;86(21):1608-17. doi: 10.1093/jnci/86.21.1608. J Natl Cancer Inst. 1994. PMID: 7932825 Clinical Trial.
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.
Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, Brienza S, Alafaci E, Bertheault-Cvitkovic F, Jasmin C, Reynes M, Bismuth H, Misset JL, Lévi F. Giacchetti S, et al. Among authors: itzhaki m. Ann Oncol. 1999 Jun;10(6):663-9. doi: 10.1023/a:1008347829017. Ann Oncol. 1999. PMID: 10442188 Free article. Clinical Trial.
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines.
Machover D, Diaz-Rubio E, de Gramont A, Schilf A, Gastiaburu JJ, Brienza S, Itzhaki M, Metzger G, N'Daw D, Vignoud J, Abad A, Francois E, Gamelin E, Marty M, Sastre J, Seitz JF, Ychou M. Machover D, et al. Among authors: itzhaki m. Ann Oncol. 1996 Jan;7(1):95-8. doi: 10.1093/oxfordjournals.annonc.a010489. Ann Oncol. 1996. PMID: 9081400 Free article. Clinical Trial.
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program.
Brienza S, Bensmaïne MA, Soulié P, Louvet C, Gamelin E, François E, Ducreux M, Marty M, André T, de Braud F, Bleiberg H, Ségal V, Itzhaki M, Cvitkovic E. Brienza S, et al. Among authors: itzhaki m. Ann Oncol. 1999 Nov;10(11):1311-6. doi: 10.1023/a:1008319600648. Ann Oncol. 1999. PMID: 10631458 Free article. Clinical Trial.
61 results